The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target

Role of CD47 as a Marker of Self on Red Blood Cells

Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 2,018

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,706

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578

Licensing of natural killer cells by host major histocompatibility complex class I molecules

Kim, S., Poursine‐Laurent, J., Truscott, S. M., Lybarger, L. P., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,328

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,124

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 1,001

Integrin-associated protein (CD47) and its ligands

Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 880

Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system

Agrawal, A., Eastman, Q. M., & Schatz, D. G. (1998) · Nature · doi:10.1038/29457 · Cited by 811

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776

Novel immunotherapy for gastric cancer: targeting the CD47–SIRPα axis

Ooki, A., Osumi, H., Shimozaki, K., & Yamaguchi, K. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10269-z · Cited by 19

Macrophages in prostate cancer: dual roles in tumor progression and immune evasion

Liu, R., Lü, J., Liu, J., Liao, Y., Guo, Y., Shi, P., Wang, Z., Wang, H., & Lai, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06519-x · Cited by 21

Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases

Lu, H., Jiang, Y., Luo, R., Zhou, D., Zheng, F., Shi, L., Zhang, H., Wang, Y., Xu, X., Zou, R., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101992 · Cited by 19

Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy

Song, F., Lin, S., Xu, T., Yang, C., Sharavyn, B., Naranmandura, H., Zhang, Y., & Huang, P. C. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101286 · Cited by 21

Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

Gondois‐Rey, F., Paul, M., Alcaraz, F., Bourass, S., Monnier, J., Malissen, N., Grob, J., Bruger, A. M., van der Bruggen, P., Gaudy‐Marqueste, C., et al. (2021) · Cancers · doi:10.3390/cancers13061362 · Cited by 19

Macrophage-Associated Disorders: Pathophysiology, Treatment Challenges, and Possible Solutions

Yadav, D. K., Pradhan, M., Singh, D., & Singh, M. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-84164-5_4 · Cited by 20

Targeting macrophage endocytosis via platelet membrane coating for advanced osteoimmunomodulation

Gao, W., Xiao, L., Mu, Y., & Xiao, Y. (2022) · iScience · doi:10.1016/j.isci.2022.105196 · Cited by 19

Upregulation of the ZNF148 / PTX3 axis promotes malignant transformation of dendritic cells in glioma stem‐like cells microenvironment

Cheng, S., Liu, L., Wang, D., Li, Y., Li, S., Yuan, J., Huang, S., Xu, Z., Jia, B., Li, Z., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14213 · Cited by 19

An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseases

Xie, M. M., Dai, B., Hackney, J. A., Sun, T., Zhang, J., Jackman, J. K., Jeet, S., Irizarry-Caro, R. A., Fu, Y., Liang, Y., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101130 · Cited by 19

Biomimetic Integrated Nanozyme for Flare and Recurrence of Gouty Arthritis

Wang, R., Liu, T., Li, X., Lu, E., Chen, Y., Luo, K., Wang, T., Huang, X., Zhang, Z., Du, S., et al. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100913 · Cited by 19

BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma

Lu, Q., Li, H., Wu, Z., Zhu, Z., Zhang, Z., Yang, D., & Tong, A. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02512-6 · Cited by 19

Novel monoclonal antibody-based therapies for acute myeloid leukemia

Morsink, L. M., & Walter, R. B. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.05.002 · Cited by 19

TSP1 ameliorates age-related macular degeneration by regulating the STAT3-iNOS signaling pathway

Li, J., He, J., Zhang, X., Li, J.-K., Zhao, P., & Fei, P. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111811 · Cited by 19

Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing

Zins, K., & Abraham, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_17 · Cited by 21

Dressing Multifunctional Nanoparticles with Natural Cell-Derived Membranes for Superior Chemotherapy

Imran, M., Paudel, K. R., Jha, S. K., Hansbro, P. M., Dua, K., & Mohammed, Y. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0051 · Cited by 19

Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation

Wusiman, D., Wang, Y., Wang, M., Wang, J., Wu, R., Tuo, Z., Wang, Z., Yu, Q., An, Z., Cho, W. C. S., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102116 · Cited by 18

Chemo‐ and mechanosensing by dendritic cells facilitate antigen surveillance in the spleen*

Liu, D., Duan, L., & Cyster, J. G. (2022) · Immunological Reviews · doi:10.1111/imr.13055 · Cited by 18

Multiple Shades of Gray—Macrophages in Acute Allograft Rejection

Lackner, K., Ebner, S., Watschinger, K., & Maglione, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098257 · Cited by 18

Compositional variations in metal nanoparticle components of welding fumes impact lung epithelial cell toxicity

Xia, L., Park, J. H., Biggs, K., Lee, C. G., Liao, L., & Shannahan, J. H. (2023) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2023.2238209 · Cited by 18

Targeted Near-Infrared Fluorescence Imaging of Liver Cancer using Dual-Peptide-Functionalized Albumin Particles

Dou, W., Guo, C., Zhu, L., Qiu, P., Kan, W., Pan, Y., Zang, Y., Dong, L., Li, J. X., Tan, Y., et al. (2023) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00078 · Cited by 18

Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection

Jia, Y., Zhang, L., Xu, J., & Xiang, L. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad46d4 · Cited by 18

The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus

L’Estrange-Stranieri, E., Gottschalk, T. A., Wright, M. D., & Hibbs, M. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395427 · Cited by 19

CD47 deficiency ameliorates autoimmune nephritis in Faslpr mice by suppressing IgG autoantibody production

Shi, L., Bian, Z., Chen, C. X.-J., Guo, Y., Lv, Z., Zeng, C., Liu, Z., Zen, K., & Liu, Y. (2015) · The Journal of Pathology · doi:10.1002/path.4574 · Cited by 18

Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease

Flies, A. S., Blackburn, N. B., Lyons, A. B., Hayball, J. D., & Woods, G. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00513 · Cited by 18

Immune-camouflaged graphene oxide nanosheets for negative regulation of phagocytosis by macrophages

Shim, G., Miao, W., Ko, S., Park, G., Kim, J., Kim, M., Kim, Y., & Oh, Y. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00648a · Cited by 18

Characterization of cluster of differentiation�47 expression and its potential as a therapeutic target in esophageal squamous cell cancer

Zhao, C., Yu, S., Wang, S., Li, S., Wang, Z., & Han, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.7447 · Cited by 18

The Physiological and Therapeutic Role of CD47 in Macrophage Function and Cancer

Bess, S. N., Igoe, M. J., & Muldoon, T. J. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2415409 · Cited by 18

Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

Toghraie, F. S., Bayat, M., Hosseini, M. S., & Ramezani, A. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01051-y · Cited by 18

Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy

Wang, Z., Wang, Y., He, Z., & Liu, C. (2025) · Advanced Science · doi:10.1002/advs.202509890 · Cited by 20

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas

Pytlík, R., Polgárová, K., Karolová, J., & Klener, P. (2020) · Vaccines · doi:10.3390/vaccines8040708 · Cited by 17

The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes

Sharp, R. C., Brown, M. E., Shapiro, M. R., Posgai, A. L., & Brusko, T. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739048 · Cited by 17

Imaging and therapeutic targeting of the tumor immune microenvironment with biologics

Arnouk, S. M., Groof, T. W. M. D., & Ginderachter, J. A. V. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114239 · Cited by 17

Anomalous Levels of CD47/Signal Regulatory Protein Alpha in the Hippocampus Lead to Excess Microglial Engulfment in Mouse Model of Perioperative Neurocognitive Disorders

Shui, M., Sun, Y., Lin, D., Xue, Z., Liu, J., Wu, A., & Wei, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.788675 · Cited by 18

Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis

Qu, S., Jiao, Z., Lu, G., Xu, J., Yao, B., Wang, T., Wang, J., Yao, Y., Yan, X., Wang, T., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.04.011 · Cited by 18

Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata

Erdem, N., Chen, K.-T., Qi, M., Zhao, Y., Wu, X., Garcia, I., Ku, H. T., Montero, E., Al-Abdullah, I. H., KANDEEL, F. R., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2022 · Cited by 17

Future prospects for the clinical transfusion of pig red blood cells

Chornenkyy, Y., Yamamoto, T., Hara, H., Stowell, S. R., Ghiran, I. C., Robson, S. C., & Cooper, D. K. C. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101113 · Cited by 17

A Biomimetic Nanoplatform with Improved Inflammatory Targeting Behavior for ROS Scavenging‐Based Treatment of Ulcerative Colitis

Wang, X., Jiao, M., Tian, F., Lu, X., Xiong, H., Liu, F., Wan, Y., Zhang, X., & Wan, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301450 · Cited by 17

SIRPα deficiency accelerates the pathologic process in models of Parkinson disease

Wang, J., Ding, X., Wu, X., Liu, J., Zhou, R., Wei, P., Zhang, Q., Zhang, C., Zen, K., & Li, L. (2019) · Glia · doi:10.1002/glia.23689 · Cited by 20

miR-148a Affects Polarization of THP-1-Derived Macrophages and Reduces Recruitment of Tumor-Associated Macrophages via Targeting SIRPα

Ma, D., Zhang, Y., Chen, G., & Jia, Y. J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s238317 · Cited by 17

The resurgent landscape of xenotransplantation of pig organs in nonhuman primates

Zhang, X., Wang, Q., Zhao, J., Li, X., Wei, P., Yang, Z.-X., Lin, Z., Yang, L., Ding, R., Tao, K., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1806-2 · Cited by 17

Temulence Therapy to Orthotopic Colorectal Tumor via Oral Administration of Fungi‐Based Acetaldehyde Generator

Zhang, Y., Zheng, D., Li, C., Pan, P., Zeng, S., Pan, T. S., & Zhang, X. (2021) · Small Methods · doi:10.1002/smtd.202100951 · Cited by 17

Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol

Fei, X., Wang, A., Wang, D., Meng, X., Ma, J., Hong, L., Qin, R., Wang, A., Dong, J., Huang, Q., et al. (2018) · BMC Immunology · doi:10.1186/s12865-018-0246-z · Cited by 17

Peptide and peptide-inspired checkpoint inhibitors: Protein fragments to cancer immunotherapy

Sasikumar, P. G., & Ramachandra, M. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100073 · Cited by 17

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

Horenstein, A. L., Faini, A. C., Morandi, F., Ortolan, E., Storti, P., Giuliani, N., Richardson, P. G. G., & Malavasi, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519300 · Cited by 16

TGN peptide and erythrocyte membrane dual-modified selenium-doped carbon quantum dots for multifaceted treatment of Alzheimer’s disease

Zhang, Y., Hong, Y., Yang, F., Yan, Y., Zhao, R., & Xie, M. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163340 · Cited by 16

Inhibitory immune checkpoints in cancer immunotherapy

Tang, Z.-H., & Veillette, A. (2025) · Science Immunology · doi:10.1126/sciimmunol.adv6870 · Cited by 16

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy

Kumar, V., Giacomantonio, M., & Gujar, S. A. (2021) · Viruses · doi:10.3390/v13040654 · Cited by 16

Thymocyte migration and emigration

Tong, Q.-Y., Yao, L., Su, M., Yang, Y., & Sun, L. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106861 · Cited by 16

Novel Drug Therapies in Myeloid Leukemia: a Patent Review

Horne, G. A., Kinstrie, R., & Copland, M. (2015) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.15.3 · Cited by 16

Tumoral and paratumoral NK cells and CD8+ T cells of esophageal carcinoma patients express high levels of CD47

Strizova, Z. O., Vachtenheim, J., Snajdauf, M., Lischke, R., Bartůňková, J., & Smrž, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-70771-y · Cited by 16

Activating the Antitumor Immune Response in Non‐Hodgkin Lymphoma Using Immune Checkpoint Inhibitors

Joshi, M., & Ansell, S. M. (2020) · Journal of Immunology Research · doi:10.1155/2020/8820377 · Cited by 16

SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells

Bahri, M., Kailayangiri, S., Vermeulen, S., Galopin, N., Rössig, C., Paris, F., Fougeray, S., & Birklé, S. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02968-7 · Cited by 16

IL-27 Derived From Macrophages Facilitates IL-15 Production and T Cell Maintenance Following Allergic Hypersensitivity Responses

Suwanpradid, J., Lee, M. J., Hoang, P., Kwock, J. T., Floyd, L. P., Smith, J. S., Yin, Z., Atwater, A. R., Rajagopal, S., Kedl, R. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713304 · Cited by 16

Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

Chan, C., Lustig, M., Baumann, N., Valerius, T., van Tetering, G., & Leusen, J. H. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932155 · Cited by 17

Blockade of CD47 function attenuates restenosis by promoting smooth muscle cell efferocytosis and inhibiting their migration and proliferation

Govatati, S., Pichavaram, P., Kumar, R., & Rao, G. N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104594 · Cited by 16

Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours

Nabbi, A., Beck, P., Delaidelli, A., Oldridge, D. A., Sudhaman, S., Zhu, K., Yang, S. Y. C., Mulder, D. T., Bruce, J. P., Paulson, J. N., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01219-x · Cited by 16

Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer

Roberts, D. D., Kaur, S., & Soto‐Pantoja, D. R. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0283-9 · Cited by 16

SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p

Deshpande, R. P., Sekhar, Y. B. V. K. C., Panigrahi, M. K., & Babu, P. P. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0302-8 · Cited by 16

Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society

Zhang, H., Deng, M., Lin, P., Liu, J., Liu, C., Strohl, W. R., Wang, S., & Ho, M. (2018) · Antibody Therapeutics · doi:10.1093/abt/tby009 · Cited by 16

Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression

Cai, S., Gao, J., Weng, X., Wang, Z., Zheng, D., Wang, Q., Li, Q., Han, C., Li, W., Chen, J., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.022 · Cited by 15

Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes

Smith, M. J., Pastor, L., Newman, J. R. B., & CONCANNON, P. J. (2021) · Diabetes · doi:10.2337/db21-0194 · Cited by 15

The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection

Tan, L., Guo, Y., Feng, C., Hou, Y., Xie, X., & Zhao, Y. X. (2021) · Engineering · doi:10.1016/j.eng.2021.10.015 · Cited by 15

Necroptosis in bacterial infections

Yu, X., Yuan, J., Shi, L.-X., Dai, S., Yue, L., & Yan, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1394857 · Cited by 15

Engineering macrophages and their derivatives: A new hope for antitumor therapy

Fang, W., Liu, H., Wang, Y., Li, Y., & Han, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116925 · Cited by 17

A patent review of glutaminyl cyclase inhibitors (2004–present)

Coimbra, J. R. M., & Salvador, J. A. R. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1917549 · Cited by 15

Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells

Ren, B., Xia, H., Liao, Y., Zhou, H., Wang, Z., Shi, Y., & Zhu, M. (2022) · eLife · doi:10.7554/elife.69219 · Cited by 15

SIRPα1-SHP2 Interaction Regulates Complete Freund Adjuvant–Induced Inflammatory Pain via Src-Dependent GluN2B Phosphorylation in Rats

Lai, C., Lin, T.-B., Hsieh, M., Chen, G., & Peng, H. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001116 · Cited by 15

Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47−/− mice from EAE

Azcutia, V., Bassil, R., Herter, J. M., Engelbertsen, D., Newton, G. A., Autio, A. K., Mayadas, T. N., Lichtman, A. H., Khoury, S. J., Parkos, C. A., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1215-546rr · Cited by 15

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer

Sharon, S., Daher-Ghanem, N., Zaid, D., Gough, M. J., & Kravchenko‐Balasha, N. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1180869 · Cited by 16

Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis

Xu, L., Wang, X., Zhang, T., Meng, X., Zhao, W., Pi, C., & Yang, Y. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101450 · Cited by 14

Mechanism of efferocytosis in atherosclerosis

Shu, L.-X., Cao, L.-L., Guo, X., Wang, Z., & Wang, S. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02439-3 · Cited by 16

CD47-mediated immune evasion in early-stage lung cancer progression

Chuang, C., Zhen, Y., Ma, J.-Y., Lee, T.-H., Hung, H.-Y., Wu, C.-C., Wang, P., Huang, C.-T., Huang, M.-S., Hsiao, M., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150066 · Cited by 15

Donor-recipient mismatch at the SIRPA locus adversely affects kidney allograft outcomes

Zhao, D., Dai, H., Macedo, C., Sanders, S. M., Elias, C., Friday, A. J., Zaidan, M., Williams, A. L., Elinoff, B. D., Oberbarnscheidt, M. H., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ady1135 · Cited by 14

SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody Production

Franke, K., Pillai, S. Y., Hoogenboezem, M., Gijbels, M. J., Matlung, H. L., Geissler, J., Olsman, H., Pöttgens, C. C. H., van Gorp, P. J., Ozsvár-Kozma, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570963 · Cited by 14

YAP Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibit Dendritic Cells Activation and Ameliorate Hepatic Ischemia-Reperfusion Injury

Yuan, Z., Ye, L., Feng, X., Zhou, T., Zhou, Y., Zhu, S., Jia, C., Li, H., Qiu, D., Li, K., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6617345 · Cited by 14

Advance of nano anticancer therapies targeted on tumor-associated macrophages

Wang, M., Zhao, J., Xiong, H., Lu, H., Jiang, H., & Wang, X. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214126 · Cited by 14

Biologically inspired stealth – Camouflaged strategies in nanotechnology for the improved therapies in various diseases

Imran, M., Gowd, V., Saha, P., Rashid, S., Chaudhary, A. A., Mohamed, M. Y. A., Alawam, A. S., & Khan, R. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122407 · Cited by 14

High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma

Meng, L., Xu, L., Yang, Y., Zhou, L., Chang, Y., Shi, T., Tan, C., An, H., Zhu, Y., & Xu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17717 · Cited by 14

A novel fully human anti-CD47 antibody as a potential therapy for human neoplasms with good safety

Yu, X., Qiu, W., Long, F., Yang, X., Zhang, C., Xu, L., Chang, H.-Y., Du, P., Hou, X., Yu, Y., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.019 · Cited by 14

CD47 receptor as a primary target for cancer therapy

Ratnikova, N. M., Lezhnin, Y. N., Frolova, E. I., Kravchenko, J. E., & Chumakov, S. P. (2017) · Molecular Biology · doi:10.1134/s0026893317010150 · Cited by 14

Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling

Nuvolone, M., Paolucci, M., Sorce, S., Kana, V., Moos, R., Matozaki, T., & Aguzzi, A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177876 · Cited by 13

Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47

Zhang, J., Zhang, C., Zang, R., Chen, W., Guo, Y., Jiang, H., Le, J., Wang, K., Fan, H., Wang, X., et al. (2025) · 癌症：英文版 · doi:10.1002/cac2.70040 · Cited by 13

CD47 inhibits phagocytosis through Vav dephosphorylation

Miller, W. D., Manion, A., Mishra, A. K., Sheedy, C. J., Bond, A., Gardner, B. M., Montell, D. J., & Morrissey, M. A. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202502206 · Cited by 13

Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma

Tomiyama, T., Itoh, S., Iseda, N., Toshida, K., Kosai‐Fujimoto, Y., Tomino, T., Kurihara, T., Nagao, Y., Morita, K., Harada, N., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-022-13058-y · Cited by 13

Hollow Mesoporous Prussian Blue Nanoparticles Loaded with Daunorubicin for Acute Myeloid Leukemia Treatment

Li, Q., Wang, F., Bai, H., Cui, Y., Ma, M., & Zhang, Y. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04297 · Cited by 13

Innate Allorecognition in Transplantation: Ancient Mechanisms With Modern Impact

Gui, Z., Moussawy, M. A., Sanders, S. M., & Abou‐Daya, K. I. (2023) · Transplantation · doi:10.1097/tp.0000000000004847 · Cited by 13

A secretory protein neudesin regulates splenic red pulp macrophages in erythrophagocytosis and iron recycling

Nakayama, Y., Masuda, Y., Mukae, T., Mikami, T., Shimizu, R., Kondo, N., Kitagawa, H., Itoh, N., & Konishi, M. (2024) · Communications Biology · doi:10.1038/s42003-024-05802-9 · Cited by 13

Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?

Qiu, J., Jiang, Y., Ye, N., Jin, G., Shi, H., & Qian, D. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05531-x · Cited by 13

Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets

Zhao, Y., Qin, C., Chen, L., Li, Z., Zhao, B., Li, T., Zhang, X., & Wang, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189183 · Cited by 14

Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes

Lustig, M., Hahn, C., Herigstad, M. L., Andersen, J. T., Leusen, J. H. W., Burger, R., & Valerius, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1488668 · Cited by 13

Immunogenic cell death and immunogenic surrender: related but distinct mechanisms of immune surveillance

Mezzapelle, R., Bianchi, M. E., & Crippa, M. P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04178-6 · Cited by 13

The biology of the tumor microenvironment in DLBCL: Targeting the “don’t eat me” signal

Ennishi, D. (2021) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.21015 · Cited by 14

Preparation and Characterization of Anti-Cancer Crystal Drugs Based on Erythrocyte Membrane Nanoplatform

Ren, L., Qiu, L., Huang, B., Yin, J., Li, Y., Yang, X., & Chen, G. (2021) · Nanomaterials · doi:10.3390/nano11102513 · Cited by 13

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

Qiang, H., Li, J., Chang, Q., Shen, Y., Qian, J., & Chu, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.835225 · Cited by 13

The phagocytic role of macrophage following myocardial infarction

Li, J., Chen, Q., Zhang, R., Liu, Z., & Cheng, Y. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10314-5 · Cited by 13

Recent advances in Extracellular Vesicles and their involvements in vasculitis

Yang, N., Zhao, Y., Wu, X., Zhang, N., Song, H., Wei, W., & Liu, M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.033 · Cited by 14

CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus

Park, J. K., Lee, Y. J., Park, J. S., Lee, E. B., & Song, Y. W. (2021) · Cells · doi:10.3390/cells10051151 · Cited by 13

Immunoglobulin-like receptors and the generation of innate immune memory

Al-Moussawy, M., Abdelsamed, H. A., & Lakkis, F. G. (2022) · Immunogenetics · doi:10.1007/s00251-021-01240-7 · Cited by 13

Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis

Pan, C., Zhu, D., Zhuo, J., Li, L., Wang, D., Zhang, C., Liu, Y., & Zen, K. (2016) · Scientific Reports · doi:10.1038/srep23710 · Cited by 13

The CD47-SIRP signalling system: its physiological roles and therapeutic application

Murata, Y., Kotani, T., Ohnishi, H., & Matozaki, T. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu017 · Cited by 171

Signal regulatory protein alpha (SIRPα)/CD47 interaction and function

Barclay, A. N. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.008 · Cited by 113

1148 Signal-regulatory protein alpha (SIRPα) confers tumor cell resistance to anti-tumor immunity

Weng, C., Hamadene, L., Eghbali, S. Z., Venkatesh, D., Monette, S., Mangarin, L. M. B., Samaan, F., Liu, C., Holland, P. M., Wolchok, J. D., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-sitc2022.1148

Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies

Lu, Q., Chen, X., Wang, S., Yu, L., Yang, C., & Jiang, G. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s249822 · Cited by 35

CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis

Morrissey, M. A., Kern, N., & Vale, R. D. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.008 · Cited by 255